ERBB2 and triple-negative breast carcinoma: Among which, the triple negative breast cancer (TNBC) was characterized by the highest mortality and proliferative rate [6], higher early recurrences rate, distant metastases and poor outcomes [7], accompanied with lacked expressions of ER, PR and human epidermal growth factor receptor-2 (HER2) [8].